US FDA Commissioner Scott Gottlieb, who seems to be the Trump Administration’s advance man on prescription drug pricing policy these days, recently signaled there may be interest in a more fundamental approach to solving the problem of rebates – making them illegal.
During a speech to the Food and Drug Law Institute annual meeting May 3, he referred to the problem of...